MedTech

The MedTech sector is evolving at an unprecedented pace, driven by the convergence of engineering, software, artificial intelligence, digital health and bioinformatics.

This shift is transforming how the industry diagnoses, treats, and cares for patients, but it also introduces complexity, especially when it comes to protecting Intellectual Property (IP).

At HGF, we work with industry-leading companies across the sector to develop agile, robust IP strategies. Whether you are developing a life-saving implant, a connected monitoring device, or a next-generation diagnostic system, our multidisciplinary team combines deep sector knowledge with technical expertise across engineering, digital health, bioinformatics, and materials science.

We act as an extension of your in-house team, leveraging deep sector insight with legal precision. With experts across a range of jurisdictions and technical fields, we offer full-spectrum IP support tailored to the fast-evolving demands of MedTech innovation.

Latest news

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our medtech specialists.